85 related articles for article (PubMed ID: 22391195)
1. [Progress of study on microRNA and chronic myeloid leukemia].
Liu H; Liu Y; Liu QF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):192-5. PubMed ID: 22391195
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance.
Navabi A; Akbari B; Abdalsamadi M; Naseri S
Life Sci; 2022 May; 296():120437. PubMed ID: 35231484
[TBL] [Abstract][Full Text] [Related]
3. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
[TBL] [Abstract][Full Text] [Related]
4. BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.
Xu C; Fu H; Gao L; Wang L; Wang W; Li J; Li Y; Dou L; Gao X; Luo X; Jing Y; Chim CS; Zheng X; Yu L
Oncogene; 2014 Jan; 33(1):44-54. PubMed ID: 23208504
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
Lopotová T; Záčková M; Klamová H; Moravcová J
Leuk Res; 2011 Jul; 35(7):974-7. PubMed ID: 21511335
[TBL] [Abstract][Full Text] [Related]
6. The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review).
Di Stefano C; Mirone G; Perna S; Marfe G
Oncol Rep; 2016 Feb; 35(2):614-24. PubMed ID: 26718125
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients.
Joshi D; Chandrakala S; Korgaonkar S; Ghosh K; Vundinti BR
Gene; 2014 Jun; 542(2):109-12. PubMed ID: 24680705
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the cross-talking of human competitive endogenous RNAs in K562 chronic myelogenous leukemia cell line.
Sen K; Sarkar A; Maji RK; Ghosh Z; Gupta S; Ghosh TC
Mol Biosyst; 2016 Nov; 12(12):3633-3642. PubMed ID: 27730241
[TBL] [Abstract][Full Text] [Related]
9. An Integrative Analysis of microRNA and mRNA Profiling in CML Stem Cells.
Nassar FJ; El Eit R; Nasr R
Methods Mol Biol; 2016; 1465():219-41. PubMed ID: 27581151
[TBL] [Abstract][Full Text] [Related]
10. Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
Cancer Lett; 2015 May; 360(2):245-56. PubMed ID: 25697481
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
Agirre X; Jiménez-Velasco A; San José-Enériz E; Garate L; Bandrés E; Cordeu L; Aparicio O; Saez B; Navarro G; Vilas-Zornoza A; Pérez-Roger I; García-Foncillas J; Torres A; Heiniger A; Calasanz MJ; Fortes P; Román-Gómez J; Prósper F
Mol Cancer Res; 2008 Dec; 6(12):1830-40. PubMed ID: 19074828
[TBL] [Abstract][Full Text] [Related]
12. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
13. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.
Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X
Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074
[TBL] [Abstract][Full Text] [Related]
14. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
[TBL] [Abstract][Full Text] [Related]
15. The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia.
Fernandes RS; Gorman AM; McGahon A; Lawlor M; McCann S; Cotter TG
Leukemia; 1996 Jun; 10 Suppl 2():s17-21. PubMed ID: 8649049
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in myeloid malignancies.
Gordon JE; Wong JJ; Rasko JE
Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M
Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191
[TBL] [Abstract][Full Text] [Related]
18. Characterization of miRNomes in acute and chronic myeloid leukemia cell lines.
Xiong Q; Yang Y; Wang H; Li J; Wang S; Li Y; Yang Y; Cai K; Ruan X; Yan J; Hu S; Fang X
Genomics Proteomics Bioinformatics; 2014 Apr; 12(2):79-91. PubMed ID: 24755403
[TBL] [Abstract][Full Text] [Related]
19. Small GTPase RAB45-mediated p38 activation in apoptosis of chronic myeloid leukemia progenitor cells.
Nakamura S; Takemura T; Tan L; Nagata Y; Yokota D; Hirano I; Shigeno K; Shibata K; Fujie M; Fujisawa S; Ohnishi K
Carcinogenesis; 2011 Dec; 32(12):1758-72. PubMed ID: 21890458
[TBL] [Abstract][Full Text] [Related]
20. A small molecule significantly inhibits the bcr/abl fusion gene at the mRNA level in human chronic myelogenous leukemia.
He Q; Dong J; Zhen H; Ying Y; Zhang J; Li Q; Li B; Zhou Y
Leuk Res; 2011 Aug; 35(8):1074-9. PubMed ID: 21163528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
